The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 11, Pages 1073
Publisher
MDPI AG
Online
2021-10-25
DOI
10.3390/jpm11111073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study
- (2021) Evgeniy Nasonov et al. ANNALS OF THE RHEUMATIC DISEASES
- Therapeutic targeting of IL-6 trans-signaling
- (2021) Stefan Rose-John CYTOKINE
- Novel Insights into Epigenetic Regulation of IL6 Pathway: In Silico Perspective on Inflammation and Cancer Relationship
- (2021) Saverio Candido et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER + Breast Cancer Cells
- (2021) Tolu Omokehinde et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer
- (2021) Carlos Martínez-Pérez et al. Journal of Personalized Medicine
- Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
- (2020) F. Mosele et al. ANNALS OF ONCOLOGY
- A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors
- (2020) Sukhvir Kaur et al. BIOORGANIC & MEDICINAL CHEMISTRY
- GP130 Cytokines in Breast Cancer and Bone
- (2020) Tolu Omokehinde et al. Cancers
- Genetic Alterations and their Association with Clinicopathologic Characteristics in Advanced Breast Carcinomas: Focusing On Clinically Actionable Genetic Alterations
- (2020) C. Eric Freitag et al. HUMAN PATHOLOGY
- The structure of the extracellular domains of human interleukin 11 α-receptor reveals mechanisms of cytokine engagement
- (2020) Riley D. Metcalfe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of bazedoxifene analogues targeting glycoprotein 130
- (2020) Dongmei Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand
- (2020) Jun W. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
- (2020) Riley D. Metcalfe et al. Frontiers in Immunology
- Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity
- (2020) Luca Falzone et al. Cancers
- Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review
- (2020) Gayathri Nagaraj et al. ADVANCES IN THERAPY
- Bazedoxifene exhibits growth suppressive activity by Targeting IL-6/GP130/STAT3 Signaling in Hepatocellular Carcinoma
- (2019) Haiyan Ma et al. CANCER SCIENCE
- Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
- (2019) Farsad Eskandary et al. Trials
- The role of oncostatin M receptor gene polymorphisms in bladder cancer
- (2019) Shi Deng et al. World Journal of Surgical Oncology
- Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
- (2019) Jia Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
- (2019) Pathum Thilakasiri et al. EMBO Molecular Medicine
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
- (2019) Masaaki Murakami et al. IMMUNITY
- Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses
- (2019) Sarah Spencer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Contribution of interaction between genetic variants of interleukin-11 and Helicobacter pylori infection to the susceptibility of gastric cancer
- (2019) Chuanwen Liao et al. OncoTargets and Therapy
- Current Perspectives in Cancer Immunotherapy
- (2019) Theodoulakis Christofi et al. Cancers
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
- (2019) Longchuan Bai et al. CANCER CELL
- The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
- (2019) Fan Liang et al. Oncogenesis
- IL11RA- related Crouzon-like autosomal recessive craniosynostosis in ten new patients: resemblances and differences
- (2018) E. Brischoux-Boucher et al. CLINICAL GENETICS
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
- (2018) Noomi Vainer et al. Oncotarget
- A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells
- (2018) Yanshu Li et al. ONCOGENE
- “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
- (2018) Emira Bousoik et al. Frontiers in Oncology
- The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
- (2018) Ali Masjedi et al. BIOMEDICINE & PHARMACOTHERAPY
- The evolving role of receptors as predictive biomarkers for metastatic breast cancer
- (2018) Carlos Martínez-Pérez et al. Expert Review of Anticancer Therapy
- Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses
- (2018) Larissa Lamertz et al. Science Signaling
- IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
- (2018) Landon Browning et al. Cancer Management and Research
- Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion
- (2018) Ken Tawara et al. Translational Oncology
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
- (2017) M.J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Do STAT3 inhibitors have potential in the future for cancer therapy?
- (2017) Andrea L.A. Wong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations
- (2017) Anne Kosfeld et al. HUMAN MOLECULAR GENETICS
- A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis
- (2017) Tobias Schwerd et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment
- (2017) Elisa Ferretti et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling
- (2017) C Lin et al. ONCOGENE
- Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
- (2017) D J Junk et al. ONCOGENE
- Severe cytokine release syndrome in a patient receiving PD-1-directed therapy
- (2017) Seth J. Rotz et al. PEDIATRIC BLOOD & CANCER
- BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation
- (2017) Valerae O. Lewis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Long non-coding RNAs as novel biomarkers for breast cancer invasion and metastasis
- (2017) Kaijiong Zhang et al. Oncology Letters
- Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signaling
- (2017) Ralph Adams et al. Scientific Reports
- Opposing Roles of Acetylation and Phosphorylation in LIFR-Dependent Self-Renewal Growth Signaling in Mouse Embryonic Stem Cells
- (2017) Xiong-jun Wang et al. Cell Reports
- Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
- (2017) Hui Xiao et al. PLoS One
- IL-6 variant is associated with metastasis in breast cancer patients
- (2017) Chike O. Abana et al. PLoS One
- Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer
- (2016) Marina Cardó-Vila et al. AMERICAN JOURNAL OF PATHOLOGY
- Current challenges of metastatic breast cancer
- (2016) Bora Lim et al. CANCER AND METASTASIS REVIEWS
- Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer
- (2016) Hanlin Zeng et al. CANCER CELL
- Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling
- (2016) Janina Wolf et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
- (2016) Marc Uemura et al. Journal of Hematology & Oncology
- Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences
- (2016) E Waanders et al. LEUKEMIA
- Targeting Interleukin-11 Receptor- Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo
- (2016) A. L. Winship et al. MOLECULAR CANCER THERAPEUTICS
- Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy
- (2016) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow
- (2016) Rachelle W. Johnson et al. NATURE CELL BIOLOGY
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Drugging the “undruggable” DNA-binding domain of STAT3
- (2016) Jian-Ting Zhang et al. Oncotarget
- Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
- (2016) Tae-Hwe Heo et al. Oncotarget
- Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings
- (2016) Chih-Ming Pan et al. Oncotarget
- Proteolytic Cleavage Governs Interleukin-11 Trans-signaling
- (2016) Juliane Lokau et al. Cell Reports
- Transcytosis of IL-11 and Apical Redirection of gp130 Is Mediated by IL-11α Receptor
- (2016) Niloufar Monhasery et al. Cell Reports
- Rationally Repurposing Ruxolitinib (Jakafi®) as a Solid Tumor Therapeutic
- (2016) Mehrad Tavallai et al. Frontiers in Oncology
- Bazedoxifene for the prevention of postmenopausal osteoporosis
- (2016) Luigi Gennari Therapeutics and Clinical Risk Management
- Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
- (2015) A. L. Wong et al. ANNALS OF ONCOLOGY
- The soluble interleukin-6 receptor and related proteins
- (2015) Stefan Rose-John BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study
- (2015) Renata Pasqualini et al. CANCER
- Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease
- (2015) Lin Sun et al. CYTOKINE
- Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
- (2015) Cameron N. Johnstone et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Mutations leading to constitutive active gp130/JAK1/STAT3 pathway
- (2015) Camilla Pilati et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology
- (2015) Heike M. Hermanns CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-6: Biology, signaling and strategies of blockade
- (2015) Fred Schaper et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
- (2015) Marine Lacroix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130
- (2015) Soon-Sun Hong et al. JOURNAL OF IMMUNOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Targeting JAK kinase in solid tumors: emerging opportunities and challenges
- (2015) M Buchert et al. ONCOGENE
- The immunobiology of myeloid-derived suppressor cells in cancer
- (2015) Morteza Motallebnezhad et al. TUMOR BIOLOGY
- Interleukin-6 as a Prognostic Marker for Breast Cancer: A Meta-analysis
- (2015) ShuChen Lin et al. TUMORI
- Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction
- (2015) Xuetian Yue et al. Oncotarget
- Interleukin-6 as a Prognostic Marker for Breast Cancer: A Meta-analysis
- (2015) ShuChen Lin et al. TUMORI JOURNAL
- Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
- (2015) Xiaokui Yu et al. PLoS One
- LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
- (2015) Xiaoyan Li et al. Oncotarget
- The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
- (2014) Christoph Garbers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
- (2014) T. Velusamy et al. BLOOD
- IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort
- (2014) Andrea Markkula et al. BMC CANCER
- Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
- (2014) Camilla Pilati et al. CANCER CELL
- Cancer-Associated Adipose Tissue Promotes Breast Cancer Progression by Paracrine Oncostatin M and Jak/STAT3 Signaling
- (2014) L. Lapeire et al. CANCER RESEARCH
- Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study
- (2014) M. L. Slattery et al. CARCINOGENESIS
- The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia
- (2014) H. L. M. Rajala et al. HAEMATOLOGICA
- LYN-activating mutations mediate antiestrogen resistance in estrogen receptor–positive breast cancer
- (2014) Luis J. Schwarz et al. JOURNAL OF CLINICAL INVESTIGATION
- Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface
- (2014) Huameng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and characterization of olokizumab
- (2014) Stevan Shaw et al. mAbs
- Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
- (2014) Andriy Marusyk et al. NATURE
- Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
- (2014) Dawn Mikelonis et al. Orphanet Journal of Rare Diseases
- The Associations between Immunity-Related Genes and Breast Cancer Prognosis in Korean Women
- (2014) Jaesung Choi et al. PLoS One
- Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition
- (2014) P. J. Lupardus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The two faces of IL-6 in the tumor microenvironment
- (2014) Daniel T. Fisher et al. SEMINARS IN IMMUNOLOGY
- Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
- (2013) Neta Erez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of intratumoral and systemic IL-6 in breast cancer
- (2013) Christine Dethlefsen et al. BREAST CANCER RESEARCH AND TREATMENT
- Soluble Interleukin-6 Receptor is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer
- (2013) Hye Sung Won et al. CANCER INVESTIGATION
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Bazedoxifene Exhibits Antiestrogenic Activity in Animal Models of Tamoxifen-Resistant Breast Cancer: Implications for Treatment of Advanced Disease
- (2013) S. E. Wardell et al. CLINICAL CANCER RESEARCH
- 201
- (2013) Tracy Putoczki et al. CYTOKINE
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
- (2013) Z. Kan et al. GENOME RESEARCH
- A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis
- (2013) Jorge Esparza-Gordillo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Oncogenic deletion mutants of gp130 signal from intracellular compartments
- (2013) D. Schmidt-Arras et al. JOURNAL OF CELL SCIENCE
- Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells
- (2013) Barbara Onnis et al. JOURNAL OF CLINICAL INVESTIGATION
- Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway
- (2013) Li Ren et al. MEDICAL ONCOLOGY
- Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer
- (2013) S. Xu et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
- (2013) Ricardo C. Ferreira et al. PLoS Genetics
- Mutations in the interleukin receptorIL11RAcause autosomal recessive Crouzon-like craniosynostosis
- (2013) Katharina Keupp et al. Molecular Genetics & Genomic Medicine
- Post-cancer fatigue is not associated with immune activation or altered cytokine production
- (2012) B. A. Cameron et al. ANNALS OF ONCOLOGY
- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
- (2012) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- A systematic review of the association between immunogenomic markers and cancer-related fatigue
- (2012) L.N. Saligan et al. BRAIN BEHAVIOR AND IMMUNITY
- Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
- (2012) Shelli Kesler et al. BRAIN BEHAVIOR AND IMMUNITY
- Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor
- (2012) Elizabeth Iorns et al. BREAST CANCER RESEARCH AND TREATMENT
- Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer
- (2012) C. F. Jehn et al. BREAST CANCER RESEARCH AND TREATMENT
- Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis
- (2012) Amir Sonnenblick et al. Clinical & Translational Oncology
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer
- (2012) Nathan R West et al. ENDOCRINE-RELATED CANCER
- Constitutively Active Mutant gp130 Receptor Protein from Inflammatory Hepatocellular Adenoma Is Inhibited by an Anti-gp130 Antibody That Specifically Neutralizes Interleukin 11 Signaling
- (2012) Jan Sommer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Breast Cancer Risk Reduction: No Pain, No Gain?
- (2012) Clifford A. Hudis et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
- (2012) Dahu Chen et al. NATURE MEDICINE
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
- (2012) Ryung S. Kim et al. PLoS One
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer
- (2011) Margaret M. Madeleine et al. BREAST CANCER RESEARCH AND TREATMENT
- TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
- (2011) Stefan Glück et al. BREAST CANCER RESEARCH AND TREATMENT
- HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis
- (2011) Z. C. Hartman et al. CANCER RESEARCH
- Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
- (2011) H. Xin et al. CANCER RESEARCH
- Association of the Oncostatin M Receptor Gene Polymorphisms with Papillary Thyroid Cancer in the Korean Population
- (2011) Il Ki Hong et al. Clinical and Experimental Otorhinolaryngology
- Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily
- (2011) Lindsay L. Jones et al. IMMUNOLOGIC RESEARCH
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
- (2011) Camilla Pilati et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
- (2011) Ingrid J. Orre et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- STAT3 SIGNALING: Anticancer Strategies and Challenges
- (2011) P. A. Johnston et al. MOLECULAR INTERVENTIONS
- Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy
- (2011) X. WANG et al. NEOPLASMA
- Azithromycin for Prevention of Exacerbations of COPD
- (2011) Richard K. Albert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research
- (2011) Michelle C. Janelsins et al. SUPPORTIVE CARE IN CANCER
- A novel small-molecule inhibitor of IL-6 signalling
- (2010) Giovanna Zinzalla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Lack of Knowledge: Breast Cancer and the Soluble Interleukin-6 Receptor
- (2010) Heike Knüpfer et al. Breast Care
- Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten
- (2010) I. Barbieri et al. CANCER RESEARCH
- Interleukin-27 Acts as Multifunctional Antitumor Agent in Multiple Myeloma
- (2010) C. Cocco et al. CLINICAL CANCER RESEARCH
- The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
- (2010) Athena Chalaris et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines
- (2010) Wiltrud Lederle et al. INTERNATIONAL JOURNAL OF CANCER
- Crystal Structure of the Entire Ectodomain of gp130
- (2010) Yibin Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
- (2010) Emma C. Walker et al. JOURNAL OF CLINICAL INVESTIGATION
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis
- (2010) G. Ishdorj et al. MOLECULAR CANCER THERAPEUTICS
- Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects
- (2009) Ke-Da Yu et al. BREAST CANCER RESEARCH AND TREATMENT
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer
- (2009) A. DeMichele et al. CANCER RESEARCH
- Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer
- (2009) J. E. Bower et al. CLINICAL CANCER RESEARCH
- N-Linked Glycosylation Is Essential for the Stability but Not the Signaling Function of the Interleukin-6 Signal Transducer Glycoprotein 130
- (2009) Georg H. Waetzig et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Significant Impairment in Immune Recovery After Cancer Treatment
- (2009) Duck-Hee Kang et al. NURSING RESEARCH
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Oncostatin M Receptor-β Mutations Underlie Familial Primary Localized Cutaneous Amyloidosis
- (2008) Ken Arita et al. AMERICAN JOURNAL OF HUMAN GENETICS
- STAT3 can be activated through paracrine signaling in breast epithelial cells
- (2008) Jacqueline C Lieblein et al. BMC CANCER
- Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
- (2008) Katriina Heikkilä et al. CANCER CAUSES & CONTROL
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
- Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner
- (2008) Adam W. Studebaker et al. CANCER RESEARCH
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- NovelSSBP2-JAK2fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia
- (2008) Jennifer L. Poitras et al. GENES CHROMOSOMES & CANCER
- Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling
- (2008) Emma C Walker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia
- (2008) Elisabetta Flex et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia
- (2008) K Nebral et al. LEUKEMIA
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
- (2008) Sandra Rebouissou et al. NATURE
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
- Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer
- (2007) Paul J. Mills et al. BRAIN BEHAVIOR AND IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More